About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Dopamine in Orthostatic Tolerance

Dopamine in Orthostatic Tolerance

NCT00748228·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Vanderbilt University

Age

18–60

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Upright plasma norepinephrine \> 600 pg/ml, or
An increase in heart rate of \> 30 beats per minute upon standing, and
Withdrawal of all medications for at least 3 days, and
No associated medical illness, and
Age 18 - 60 years old.

You may not be if

Older than 60 years of age
Routinely taking medications affecting the autonomic nervous system
Any chronic illness (cardiac, pulmonary, endocrine, gastrointestinal, rheumatologic) other than POTS
Anemia (Hct \< 30)
Women of childbearing age who are pregnant or nursing
Unable to give informed consent

The record

StatusTerminated

PhaseNo phase

Taking part22

StartedNov 2004

UpdatedJun 15, 2015

Conditions

Postural Tachycardia Syndrome

Where1

Vanderbilt University
Nashville, Tennessee, United States